- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00139997
Environmental Treatment for Seasonal Affective Disorder (SAD)
A Multicenter, Randomized Controlled Trial of Negative Ion Generation Versus Light-Emitting Diode Phototherapy For Seasonal Affective Disorder
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a multicenter, randomized controlled trial of negative ion generation versus light-emitting diode phototherapy for seasonal affective disorder. Participants appropriate for the study are subjects with a DSM IV diagnosis of Major Depression, with seasonal pattern, winter type. Subjects were seen at Yale University,New Haven,CT University of British Columbia,Vancouver,BC Groningen University Hospital,Groningen, The Netherlands, Royal Ottawa Hospital, Ottawa,Ontario, McGill University, Montreal,Quebec, University Hospital,Saskatoon, Saskatchewan. The trial is 4 weeks in duration.
This trial has now been completed.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6T 2A1
- University of British Columbia
-
-
Ontario
-
Ottawa, Ontario, Canada, K1Z 7K4
- Royal Ottawa Mental Health Centre, , Ontario, K1Z 7K4 Canada
-
-
Quebec
-
Montreal, Quebec, Canada, H4H 1R3
- Douglas Hospital Research Centre
-
-
-
-
RB
-
Groningen, RB, Netherlands, 9700
- University Medical Center Groningen
-
-
-
-
Connecticut
-
New Haven, Connecticut, United States, 06504
- Yale University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subjects meet DSM-IV criteria for major depressive episodes with a seasonal pattern, winter type.
Exclusion Criteria:
- Significant suicidal risk
- Serious medical illness
- Pregnancy
- Other DSM-IV diagnoses
- Taking mood altering medication
- May not travel to a sunny destination during study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: LED phototherapy device
Litebook treatment devices: LED phototherapy device, used for 30 min before 8 am
|
Litebook LED phototherapy device used for 30 min before 8 am
|
Placebo Comparator: Inactivated Negative Ion Generator
Equivalent exposure to inactivated negative ion generator
|
Equivalent exposure to inactivated negative ion generator
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage SIGH SAD (Structured Interview Guide For The Hamilton Depression Rating Scale), SAD Version
Time Frame: Week 4
|
SIGH SAD Structured Interview Guide for the Hamilton Depression Rating Scale, Seasonal Affective Disorder (SAD)version. The items are augmented with additional items to reflect better the atypical depressive symptoms usually seen in SAD, eg, increased sleep, weight, appetite and fatigue. On this scale, higher scores reflect increased depression intensity. The maximum score attainable is 63, and the minimum is 0. A score of less than 9 is regarded as consistent with normal mood, the absence of major depression. Calculated: SIGH SAD score at trial end x 100 / SIGH SAD score at randomization |
Week 4
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
SIGH SAD (Structured Interview Guide For The Hamilton Depression Rating Scale), SAD Version
Time Frame: Weekly following randomization
|
SIGH SAD Structured Interview Guide for the Hamilton Depression Rating Scale, SIGH SAD Structured Interview Guide for the Hamilton Depression Rating Scale, Seasonal Affective Disorder (SAD)version.
This is a structured interview, which is an interview in which the clinician is provided exact questions to use to inquire about symptoms of depression and explicit standards for rating the intensity of each symptom item.
The interview assesses the symptoms which make up the Hamilton Depression Rating Scale, which is the standard in the majority of clinical trials in depression.
The items are augmented with additional items to reflect better the atypical depressive symptoms usually seen in SAD, eg, increased sleep, weight, appetite and fatigue.
On this scale, higher scores reflect increased depression intensity.
The maximum score attainable is 63, and the minimum is 0. A score of less than 9 is regarded as consistent with normal mood, the absence of major depression.
|
Weekly following randomization
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Paul H. Desan, PhD, MD, Yale New Haven Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 22,777 (Other Identifier: Yale University)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Seasonal Affective Disorder
-
GlaxoSmithKlineCompleted
-
University of OuluCompletedSeasonal Affective Disorder (SAD)Finland
-
University Medical Center GroningenCompletedSeasonal Affective DisorderNetherlands
-
Medical University of ViennaCompletedSeasonal Affective DisorderAustria
-
Thomas Jefferson UniversityApollo Health SystemsCompletedSeasonal Affective DisorderUnited States
-
University of OuluOulu University Hospital; University of Eastern Finland; ODL Terveys Oy; Valkee OyUnknownSeasonal Affective DisorderFinland
-
University of VermontNational Institute of Mental Health (NIMH)CompletedSeasonal Affective Disorder (SAD) | Winter Depression | Major Depressive Disorder, Recurrent, With Seasonal PatternUnited States
-
University of VermontUniversity of Pittsburgh; University of Maryland School of MedicineActive, not recruitingSeasonal Affective DisorderUnited States
-
ProofPilotJoovvCompletedSeasonal Affective DisorderUnited States
-
Yale UniversityUniversity of British Columbia; McGill University Health Centre/Research Institute... and other collaboratorsCompletedSeasonal Affective DisorderUnited States, Canada, Netherlands
Clinical Trials on Litebook treatment devices
-
Mclean HospitalLiteBook Company LtdCompletedSleepiness, DaytimeUnited States
-
Aarhus University HospitalRecruitingCancer-related Fatigue | Cancer-related Cognitive ImpairmentDenmark
-
University of California, San DiegoRetirement Research FoundationUnknownDepression | Stage B Heart FailureUnited States
-
Cairo UniversityUniversity of KielCompleted
-
Icahn School of Medicine at Mount SinaiCompletedFatigue | Traumatic Brain InjuryUnited States
-
University of WashingtonIcahn School of Medicine at Mount Sinai; University of North Texas Health Science...CompletedSleep | Traumatic Brain Injury | TBIUnited States
-
Microvention-Terumo, Inc.RecruitingStroke | Acute Ischemic Stroke | Ischemic | Vessel OcclusionUnited States
-
M.D. Anderson Cancer CenterTerminatedAdvanced CancersUnited States
-
University of CalgaryCanadian Cancer Society (CCS)Completed
-
University of South CarolinaLiteboook CompanyCompleted